Page 15 - Sight Sciences News Today

Operator: Good day, and thank you for standing by. Welcome to the Sight Sciences Third Quarter 2022 Earnings Results Conference Call. At this time, all participants are in a listen-only mode.

Improvements in Signs and Symptoms of Dry Eye Disease From a Single TearCare® Treatment Sustained Through 12 Months - read this article along with other careers information, tips and advice on BioSpace

NEW YORK — Patients with post-refractive corneas are not necessarily excluded from undergoing premium IOL implantation, according to an expert at OSN New York.

Deloitte today released its "North America Technology Fast 500" list of growing companies, including a handful of medtech firms.

Sight Sciences (NASDAQ:SGHT – Get Rating) will be releasing its earnings data after the market closes on Thursday, November 10th. Analysts expect Sight Sciences to post earnings of ($0.47) per share for the quarter. Investors that are interested in participating in the company’s conference call can do so using this link. Sight Sciences (NASDAQ:SGHT – […]

Ocular Surgery News | The 2022 Digital Ophthalmic Society meeting was the first ever eye care conference to be held in a space station, or at least that is what it looked like. The attendees were able to hop around the galactic convention center and zip around on helicopters because they were in a virtual reality space known as the metaverse. Connecting with colleagues in different parts of the world has become

MENLO PARK, Calif., Oct. 20, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative...

Innovation finds its way into all areas of medtech, and ophthalmic treatments represent another burgeoning space.

Sight Sciences announced today that 36-month data supports the use of its Omni surgical system.

SGHT earnings call for the period ending June 30, 2022.